Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAYANA: Simplified ART in Naive HIV-1 Patients
NCT00573001Phase 3Completed
- Sponsor
- ANRS
- Start
- Jul 2008
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of tenofovir, emtricitabine, nevirapine, lopinavir, ritonavir and 1 more in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Jul 2008; status: completed.
02
Drugs
tenofoviremtricitabinenevirapinelopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00573001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573001.